These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 8840303

  • 1. New insights into the regulation of parathyroid hormone synthesis and secretion in chronic renal failure.
    Silver J, Moallem E, Kilav R, Epstein E, Sela A, Naveh-Many T.
    Nephrol Dial Transplant; 1996; 11 Suppl 3():2-5. PubMed ID: 8840303
    [Abstract] [Full Text] [Related]

  • 2. Calcium, phosphate, vitamin D, and the parathyroid.
    Marks KH, Kilav R, Naveh-Many T, Silver J.
    Pediatr Nephrol; 1996 Jun; 10(3):364-7. PubMed ID: 8792407
    [Abstract] [Full Text] [Related]

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 4. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
    Soliman E, Canaff L, Fox J, Hendy GN.
    Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
    [Abstract] [Full Text] [Related]

  • 5. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.
    Naveh-Many T, Rahamimov R, Livni N, Silver J.
    J Clin Invest; 1995 Oct; 96(4):1786-93. PubMed ID: 7560070
    [Abstract] [Full Text] [Related]

  • 6. Regulation of parathyroid hormone synthesis in chronic renal failure in rats.
    Fukagawa M, Kaname S, Igarashi T, Ogata E, Kurokawa K.
    Kidney Int; 1991 May; 39(5):874-81. PubMed ID: 2067203
    [Abstract] [Full Text] [Related]

  • 7. Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids.
    Russell J, Bar A, Sherwood LM, Hurwitz S.
    Endocrinology; 1993 Jun; 132(6):2639-44. PubMed ID: 8389284
    [Abstract] [Full Text] [Related]

  • 8. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
    Brown AJ, Zhong M, Finch J, Ritter C, Slatopolsky E.
    Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
    [Abstract] [Full Text] [Related]

  • 9. Calreticulin inhibits vitamin D's action on the PTH gene in vitro and may prevent vitamin D's effect in vivo in hypocalcemic rats.
    Sela-Brown A, Russell J, Koszewski NJ, Michalak M, Naveh-Many T, Silver J.
    Mol Endocrinol; 1998 Aug; 12(8):1193-200. PubMed ID: 9717845
    [Abstract] [Full Text] [Related]

  • 10. Insulin modulates the stimulation of renal 1,25-dihydroxyvitamin D3 production by parathyroid hormone.
    Wongsurawat N, Armbrecht HJ.
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):243-8. PubMed ID: 3893009
    [Abstract] [Full Text] [Related]

  • 11. [Vitamin D metabolism in kidney insufficiency: disorders of an endocrine regulatory zone].
    Ritz E, Kreusser W, Boland R, Bommer J.
    Klin Wochenschr; 1979 Oct 01; 57(19):1053-9. PubMed ID: 392179
    [Abstract] [Full Text] [Related]

  • 12. Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease.
    Silver J, Levi R.
    Kidney Int Suppl; 2005 Jun 01; (95):S8-12. PubMed ID: 15882315
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The assay of 1alpha,25-dihydroxyvitamin D3: physiologic and pathologic modulation of circulating hormone levels.
    Haussler MR, Baylink DJ, Hughes MR, Brumbaugh PF, Wergedal JE, Shen FH, Nielsen RL, Counts SJ, Bursac KM, McCain TA.
    Clin Endocrinol (Oxf); 1976 Jun 01; 5 Suppl():151S-165S. PubMed ID: 212227
    [Abstract] [Full Text] [Related]

  • 15. Cellular and molecular mechanisms of secondary hyperparathyroidism.
    Silver J, Levi R.
    Clin Nephrol; 2005 Feb 01; 63(2):119-26. PubMed ID: 15730054
    [Abstract] [Full Text] [Related]

  • 16. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
    Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ.
    J Clin Invest; 1984 Dec 01; 74(6):2136-43. PubMed ID: 6549016
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of secondary hyperparathyroidism.
    Silver J, Kilav R, Naveh-Many T.
    Am J Physiol Renal Physiol; 2002 Sep 01; 283(3):F367-76. PubMed ID: 12167586
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of parathyroid hormone on the renal 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 production of young and adult rats.
    Armbrecht HJ, Wongsurawat N, Zenser TV, Davis BB.
    Endocrinology; 1982 Oct 01; 111(4):1339-44. PubMed ID: 6981502
    [Abstract] [Full Text] [Related]

  • 19. The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.
    Brown AJ, Ritter CR, Finch JL, Morrissey J, Martin KJ, Murayama E, Nishii Y, Slatopolsky E.
    J Clin Invest; 1989 Sep 01; 84(3):728-32. PubMed ID: 2760211
    [Abstract] [Full Text] [Related]

  • 20. High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro.
    Almaden Y, Hernandez A, Torregrosa V, Canalejo A, Sabate L, Fernandez Cruz L, Campistol JM, Torres A, Rodriguez M.
    J Am Soc Nephrol; 1998 Oct 01; 9(10):1845-52. PubMed ID: 9773785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.